Brian L. Pearlman, MD
Medical Director, Center for Hepatitis C
Atlanta Medical Center

Clinical Professor of Medicine
Medical College of Georgia

Associate Clinical Professor of Medicine
Emory University School of Medicine
Atlanta, Georgia


Brian L. Pearlman, MD, is Clinical Professor of Medicine at the Medical College of Georgia and Associate Clinical Professor of Medicine, Emory University School of Medicine, both in Atlanta. Dr. Pearlman serves as Faculty Physician in the Department of Internal Medicine and Medical Director at the Center for Hepatitis C at the Atlanta Medical Center. He is board certified in Internal Medicine.

Dr. Pearlman earned his medical degree and completed the honors program in medical education from the University of Miami School of Medicine, Florida. He completed his Radiology residency at the University of Texas Southwestern Medical Center and Parkland Memorial Hospital in Dallas. He performed his Internal Medicine residency at Baylor University Medical Center in Dallas.

Dr. Pearlman is a member of the American Association for the Study of Liver Disease, American Gastroenterological Association, American Academy of HIV Medicine, and American College of Physicians-American Society of Internal Medicine. Dr. Pearlman has contributed to peer-reviewed articles on Hepatitis C in publications such as Clinical Infectious Disease, American Journal of Medicine, and Gastroenterology, as well as abstracts at numerous AASLD annual meetings. He is currently a reviewer for Gastroenterology and Alimentary Pharmacology and Therapeutics.

Dr. Pearlman presents nationally and has recently completed 3 clinical research studies on hepatitis C as Site Principal Investigator for REACH SVR, a registry study for consensus interferon; Principal Investigator for a study on the retreatment of chronic hepatitis C-genotype1-relapsers; and as co-principal investigator in collaboration with the CDC's Division of Viral Hepatitis studying outcomes of antiviral therapy among African Americans and Non-Hispanic Whites with chronic hepatitis C.